EASTERLY INVESTMENT PARTNERS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1766150
BEVERLY, MA
Position in REGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,240,537
+$1,886,100 QoQ
Shares Held
5,197
+196.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#444
of 1,322 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EASTERLY INVESTMENT PARTNERS LLC holds $22,742,515 across 3 Biotechnology names. REGN ranks #2 (14.2% of the industry book) .
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,240,537 | 5,197 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,354,437 | 1,753 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,365,438 | 1,769 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $977,225 | 1,738 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||